Barr reaches licensing deal with Bayer
-
- June
- 24
Barr Pharmaceuticals Inc. of Montvale, N.J., with research and manufacturing operations in Pomona, said it has a deal to market and distribute generic versions of Bayer’s Yasmin and Yaz oral contraceptives in the United States. Bayer will provide the drugs to Barr before the patents expire, and Barr will sell them under the Barr Laboratories label. Barr said the deal allows the company to launch its own authorized generic versions of the drugs years before the patent expirations. Yasmin had reported sales of $575 million in the 12 months ending in April, while Yaz had sales of $384 million in that period.
This entry was posted
on Tuesday, June 24th, 2008 at 5:12 pm by Jerry Gleeson.
You can follow any responses to this entry through the RSS 2.0 feed.
Print
| 
Email
